Pfammatter Cyrill, Hambrecht Jan, Kalbas Yannik, Neuhaus Valentin, Hierholzer Christian, Canal Claudio
Department of Traumatology, University Hospital Zurich, Zurich, 8091, Switzerland.
Department of Surgical Research, Harald Tscherne Laboratory for Orthopedic and Trauma Research, University Hospital Zurich, Zurich, 8091, Switzerland.
Eur J Trauma Emerg Surg. 2025 Feb 7;51(1):94. doi: 10.1007/s00068-025-02769-y.
The use of preoperative antibiotic prophylaxis (POAP) in elective implant removal (IR) is controversial due to a lack of evidence-based recommendations. First-generation cephalosporins, which are commonly used in orthopedic IR, are believed to reduce wound infection risks. However, the potential for serious side effects had raised concerns about their necessity. This study was intended to evaluate whether omitting POAP in small IR increases the risk of wound infections.
This retrospective, single-centre cohort study was conducted at a level I trauma centre in Switzerland, including patients who underwent IR between January 1, 2016, and December 31, 2021. The IR procedures involved the upper extremities (UEs), such as the clavicle, olecranon, radius and ulna, as well as the lower extremities (LEs), such as the patella, tibia, fibula, (bi)malleolar and foot. Postoperative follow-up included clinical and radiological evaluations 6 weeks after surgery. The outcomes assessed were deep wound infections, wound healing complications, refractures, persistent pain, bleeding, neurovascular injuries and muscle hernias.
Of the 273 patients (mean age: 42.1 ± 14.5; 44% female), 117 (42.9%) received POAP. In the LE group (n = 141), 51.1% received POAP; in the UE group (n = 132), 34.1% received POAP. Eleven (4.0%) wound-healing disorders were documented, with five (4.3%) in the POAP group and six (3.8%) in the non-POAP group (p = 1). No deep wound infections were observed.
Withholding POAP in elective IR procedures does not significantly increase wound infection rates, suggesting it may be unnecessary in uncomplicated cases.
由于缺乏循证医学推荐,择期植入物取出术(IR)中术前预防性使用抗生素(POAP)存在争议。常用于骨科IR的第一代头孢菌素被认为可降低伤口感染风险。然而,其严重副作用的可能性引发了对其必要性的担忧。本研究旨在评估在小型IR中省略POAP是否会增加伤口感染风险。
本回顾性单中心队列研究在瑞士的一级创伤中心进行,纳入2016年1月1日至2021年12月31日期间接受IR的患者。IR手术涉及上肢(UE),如锁骨、尺骨鹰嘴、桡骨和尺骨,以及下肢(LE),如髌骨、胫骨、腓骨、(双)踝和足部。术后随访包括术后6周的临床和影像学评估。评估的结果包括深部伤口感染、伤口愈合并发症、再骨折、持续疼痛、出血、神经血管损伤和肌肉疝。
273例患者(平均年龄:42.1±14.5岁;44%为女性)中,117例(42.9%)接受了POAP。在LE组(n = 141)中,51.1%接受了POAP;在UE组(n = 132)中,34.1%接受了POAP。记录到11例(4.0%)伤口愈合障碍,POAP组5例(4.3%),非POAP组6例(3.8%)(p = 1)。未观察到深部伤口感染。
在择期IR手术中不使用POAP不会显著增加伤口感染率,表明在无并发症的情况下可能无需使用。